Zhong Z et al. (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science264: 95–98 ArticleCAS Google Scholar
Yu CL et al. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science269: 81–83 ArticleCAS Google Scholar
Yu H and Jove R (2004) The STATs of cancer—new molecular targets come of age. Nat Rev Cancer4: 97–105 ArticleCAS Google Scholar
Wen Z et al. (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell82: 241–250 ArticleCAS Google Scholar
Bild AH et al. (2002) Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J21: 3255–3263 ArticleCAS Google Scholar
Zhang X et al. (1999) Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol Cell Biol19: 7138–7146 ArticleCAS Google Scholar
Starr R et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature387: 917–921 ArticleCAS Google Scholar
Chung CD et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science278: 1803–1805 ArticleCAS Google Scholar
Lufei C et al. (2003) GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J22: 1325–1335 ArticleCAS Google Scholar
Reljic R et al. (2000) Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med192: 1841–1848 ArticleCAS Google Scholar
He B et al. (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A100: 14133–14138 ArticleCAS Google Scholar
Shen Y et al. (2001) Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A98: 1543–1548 ArticleCAS Google Scholar
Catlett-Falcone R et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity10: 105–115 ArticleCAS Google Scholar
Epling-Burnette PK et al. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest107: 351–362 ArticleCAS Google Scholar
Real PJ et al. (2002) Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene21: 7611–7618 ArticleCAS Google Scholar
Gritsko TT et al. Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res, in press
Diaz NM et al. (2005) Activation of Stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated Src and Survivin expression. Clin Cancer Res, in press Google Scholar
Niu G et al. (2001) Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res61: 3276–3280 CASPubMed Google Scholar
Kiuchi N et al. (1999) STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med189: 63–73 ArticleCAS Google Scholar
Sinibaldi D et al. (2000) Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene19: 5419–5427 ArticleCAS Google Scholar
Niu G et al. (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene21: 2000–2008 ArticleCAS Google Scholar
Wang T et al. (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med10: 48–54 Article Google Scholar
Cheng F et al. (2003) A critical role for Stat3 signaling in immune tolerance. Immunity19: 425–36 ArticleCAS Google Scholar
Xie TX et al. (2004) Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene23: 3550–3560 ArticleCAS Google Scholar
Dauer DJ et al. (2005) Stat3 regulates genes common to both wound healing and cancer. Oncogene24: 3397–3408 ArticleCAS Google Scholar
Xi S et al. (2003) Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res63: 6763–6771 CASPubMed Google Scholar
Kazansky AV et al. (2003) Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. Cancer Res63: 8757–8762 CASPubMed Google Scholar
Huang M et al. (2002) Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene21: 8804–8816 ArticleCAS Google Scholar
Horita M et al. (2000) Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med191: 977–984 ArticleCAS Google Scholar
Nieborowska-Skorska M et al. (2002) Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood99: 4531–4539 ArticleCAS Google Scholar
Li H et al. (2004) Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Res64: 4774–4782 ArticleCAS Google Scholar
Nevalainen MT et al. (2004) Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol22: 2053–2060 ArticleCAS Google Scholar
Durbin JE et al. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell84: 443–450 ArticleCAS Google Scholar
Kaplan DH et al. (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A95: 7556–7561 ArticleCAS Google Scholar
Bromberg JF et al. (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A93: 7673–7678 ArticleCAS Google Scholar
Chin YE et al. (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science272: 719–722 ArticleCAS Google Scholar
Sun WH et al. (1998) Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood91: 570–576 CASPubMed Google Scholar
Chen B et al. (2000) Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res60: 3290–3298 CASPubMed Google Scholar
Ramana CV et al. (2000) Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J19: 263–272 ArticleCAS Google Scholar
Sironi JJ and Ouchi T (2003). STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem279: 4066–4074 Article Google Scholar
Stephanou A et al. (2000) Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ7: 329–330 ArticleCAS Google Scholar
Thomas M et al. (2004) STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res64: 8357–8364 ArticleCAS Google Scholar
Huang S (2002). Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene21: 2504–2512 ArticleCAS Google Scholar
Widschwendter A et al. (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res8: 3065–3074 CASPubMed Google Scholar
Mora LB et al. (2002) Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res62: 6659–6666 CASPubMed Google Scholar
Grandis JR et al. (2000) Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A97: 4227–4232 ArticleCAS Google Scholar
Song L et al. (2003) Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene22: 4150–4165 ArticleCAS Google Scholar
Garcia R et al. (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene20: 2499–2513 ArticleCAS Google Scholar
Gao H et al. (2004) Stat3 activation in acute lung injury. J Immunol172: 7703–7712 ArticleCAS Google Scholar
Hokuto I et al. Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest113: 28–37
Sano S et al. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J18: 4657–6468 ArticleCAS Google Scholar
Kano A et al. (2003) Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med198: 1517–1525 ArticleCAS Google Scholar
Chan KS et al. (2004) Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest114: 720–728 ArticleCAS Google Scholar
Greten FR et al. (2002) Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology123: 2052–2063 ArticleCAS Google Scholar
Sanchez A et al. (2003) STAT-3 activity in chemically-induced hepatocellular carcinoma. Eur J Cancer39: 2093–2098 ArticleCAS Google Scholar
Ren S et al. (2002) Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene21: 4335–4339 ArticleCAS Google Scholar
Nikitakis NG et al. (2002) The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells. Cancer Res62: 1004–1007 CASPubMed Google Scholar
Turkson J (2004) STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets8: 409–422 ArticleCAS Google Scholar
Blaskovich MA et al. (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res63: 1270–1279 CASPubMed Google Scholar
Turkson J et al. (2004) Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent anti-tumor activity. Mol Cancer Ther3: 1–10 Article Google Scholar
Turkson J et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation and cell transformation. J Biol Chem276: 45443–45455 ArticleCAS Google Scholar
Ren Z et al. (2003) Identification of a high-affinity phosphopeptide inhibitor of stat3. Bioorg Med Chem Lett13: 633–636 ArticleCAS Google Scholar
Nagel-Wolfrum K et al. (2004) The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Mol Cancer Res2: 170–182 CASPubMed Google Scholar
Jing N et al. (2003) Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells. DNA Cell Biol22: 685–696 ArticleCAS Google Scholar
Leong PL et al. (2003) Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci U S A100: 4138–4143 ArticleCAS Google Scholar
Konnikova L et al. (2003) Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer3: 23 Article Google Scholar
Yin N et al. (2004) Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res64: 5870–5875 ArticleCAS Google Scholar
Giraud S et al. (2002) Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem277: 8004–8011 ArticleCAS Google Scholar